Amedeo Smart

Free Medical Literature Service


 

Amedeo

Vaccines

  Free Subscription

18.07.2022

1 Arch Virol
5 BMJ
1 J Gen Virol
1 JAMA
1 Lancet
1 MMWR Morb Mortal Wkly Rep
1 N Engl J Med
1 Nat Immunol
3 Pediatrics
6 PLoS One
13 Vaccine
1 Virus Res



    Arch Virol

  1. JUNG JS, Lee R, Yoon SI, Lee GS, et al
    Genetic and immunological characterization of commercial infectious bronchitis virus vaccines used in Korea.
    Arch Virol. 2022 Jul 11. pii: 10.1007/s00705-022-05519.
    >> Share


    BMJ

  2. ANDERSSON NW, Thiesson EM, Laursen MV, Mogensen SH, et al
    Safety of heterologous primary and booster schedules with ChAdOx1-S and BNT162b2 or mRNA-1273 vaccines: nationwide cohort study.
    BMJ. 2022;378:e070483.
    >> Share

  3. REZA HM, Agarwal V, Sultana F, Bari R, et al
    Why are vaccination rates lower in low and middle income countries, and what can we do about it?
    BMJ. 2022;378:e069506.
    >> Share

  4. WISE J
    Covid-19: MPs call for greater efforts to reach the unvaccinated and partially vaccinated.
    BMJ. 2022;378:o1743.
    >> Share

  5. PILLAY J, Gaudet L, Wingert A, Bialy L, et al
    Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review.
    BMJ. 2022;378:e069445.
    >> Share

  6. BLOCK J
    Covid-19: Researchers face wait for patient level data from Pfizer and Moderna vaccine trials.
    BMJ. 2022;378:o1731.
    >> Share


    J Gen Virol

  7. SHARTOUNY JR, Lowen AC
    Message in a bottle: mRNA vaccination for influenza.
    J Gen Virol. 2022;103.
    >> Share


    JAMA

  8. KUEHN BM
    Newer Poxvirus Vaccine Is Recommended.
    JAMA. 2022;328:123.
    >> Share


    Lancet

  9. MELLO MM, Opel DJ, Benjamin RM, Callaghan T, et al
    Effectiveness of vaccination mandates in improving uptake of COVID-19 vaccines in the USA.
    Lancet. 2022 Jul 8. pii: S0140-6736(22)00875.
    >> Share


    MMWR Morb Mortal Wkly Rep

  10. SINGSON JRC, Kirley PD, Pham H, Rothrock G, et al
    Factors Associated with Severe Outcomes Among Immunocompromised Adults Hospitalized for COVID-19 - COVID-NET, 10 States, March 2020-February 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:878-884.
    >> Share


    N Engl J Med

  11. RUBIN EJ, Baden LR, Marks P, Morrissey S, et al
    Audio Interview: Covid-19 Vaccines and the FDA.
    N Engl J Med. 2022;387:e10.
    >> Share


    Nat Immunol

  12. YU D, Walker LSK, Liu Z, Linterman MA, et al
    Targeting TFH cells in human diseases and vaccination: rationale and practice.
    Nat Immunol. 2022 Jul 11. pii: 10.1038/s41590-022-01253.
    >> Share


    Pediatrics

  13. WARREN MD, Hanna MF
    Vaccines Are Profoundly Effective-And We Can't Stop There.
    Pediatrics. 2022 Jul 13. pii: 188496. doi: 10.1542/peds.2022-057831.
    >> Share

  14. TALBIRD SE, Carrico J, La EM, Carias C, et al
    Impact of Routine Childhood Immunization in Reducing Vaccine-Preventable Diseases in the US.
    Pediatrics. 2022 Jul 13. pii: 188495. doi: 10.1542/peds.2021-056013.
    >> Share

  15. GILKEY MB, Grabert BK, Heisler-MacKinnon J, Bjork A, et al
    Coaching and Communication Training for HPV Vaccination: A Cluster Randomized Trial.
    Pediatrics. 2022 Jul 12. pii: 188506. doi: 10.1542/peds.2021-052351.
    >> Share


    PLoS One

  16. SEREDA AD, Kazakova AS, Namsrayn SG, Vlasov ME, et al
    The attenuated ASFV strains MK-200 and FK-32/135 as possible models for investigation of protective immunity by ASFV infection.
    PLoS One. 2022;17:e0270641.
    >> Share

  17. EL MANSOURI N, Ferrera L, Kharbach A, Achbani A, et al
    Awareness and knowledge associated to Human papillomavirus infection among university students in Morocco: A cross-sectional study.
    PLoS One. 2022;17:e0271222.
    >> Share

  18. KONISHI T
    Mutations in SARS-CoV-2 are on the increase against the acquired immunity.
    PLoS One. 2022;17:e0271305.
    >> Share

  19. TEGEGNE MD, Girma S, Mengistu S, Mesfin T, et al
    Willingness to receive COVID-19 vaccine and associated factors among adult chronic patients. A cross-sectional study in Northwest Ethiopia.
    PLoS One. 2022;17:e0269942.
    >> Share

  20. BEYEN MW, Bulto GA, Chaka EE, Debelo BT, et al
    Human papillomavirus vaccination uptake and its associated factors among adolescent school girls in Ambo town, Oromia region, Ethiopia, 2020.
    PLoS One. 2022;17:e0271237.
    >> Share

  21. KUMAR CK, Balasubramanian R, Ongarello S, Carmona S, et al
    SARS-CoV-2 testing strategies for outbreak mitigation in vaccinated populations.
    PLoS One. 2022;17:e0271103.
    >> Share


    Vaccine

  22. REINHARDT A, Rossmann C, Engel E
    Radio public service announcements to promote vaccinations for older adults: Effects of framing and distraction.
    Vaccine. 2022 Jul 6. pii: S0264-410X(22)00805.
    >> Share

  23. CHADWICK C, Friede M, Moen A, Nannei C, et al
    Technology transfer programme for influenza vaccines - Lessons from the past to inform the future.
    Vaccine. 2022 Jul 6. pii: S0264-410X(22)00826.
    >> Share

  24. XIRIDOU M, Adam P, Meiberg A, Visser M, et al
    The impact of the COVID-19 pandemic on hepatitis B virus vaccination and transmission among men who have sex with men: A mathematical modelling study.
    Vaccine. 2022 Jul 4. pii: S0264-410X(22)00847.
    >> Share

  25. WONG SC, Chan VW, Lam GKM, Yuen LL, et al
    The impact of personal coaching on influenza vaccination among healthcare workers before and during COVID-19 pandemic.
    Vaccine. 2022 Jun 27. pii: S0264-410X(22)00836.
    >> Share

  26. OSTROPOLETS A, Shoener Dunham L, Johnson KD, Liu J, et al
    Pneumococcal vaccination coverage among adults newly diagnosed with underlying medical conditions and regional variation in the U.S.
    Vaccine. 2022 Jul 5. pii: S0264-410X(22)00837.
    >> Share

  27. MCCORMICK DW, Konkle SL, Magleby R, Chakrabarti AK, et al
    SARS-CoV-2 infection risk among vaccinated and unvaccinated household members during the Alpha variant surge - Denver, Colorado, and San Diego, California, January-April 2021.
    Vaccine. 2022 Jul 4. pii: S0264-410X(22)00835.
    >> Share

  28. BADRAN G, Angrand L, Masson JD, Crepeaux G, et al
    Physico-chemical properties of aluminum adjuvants in vaccines: Implications for toxicological evaluation.
    Vaccine. 2022 Jul 6. pii: S0264-410X(22)00833.
    >> Share

  29. ZHANG Y, Wang Y, Jia C, Li G, et al
    Immunogenicity and safety of an egg culture-based quadrivalent inactivated non-adjuvanted subunit influenza vaccine in subjects >/=3 years: A randomized, multicenter, double-blind, active-controlled phase III, non-inferiority trial.
    Vaccine. 2022 Jul 7. pii: S0264-410X(22)00846.
    >> Share

  30. MISCHLINGER J, Jaeger VK, Ciurea A, Gabay C, et al
    Long-term persistence of antibodies after diphtheria/tetanus vaccination in immunosuppressed patients with inflammatory rheumatic diseases and healthy controls.
    Vaccine. 2022 Jul 7. pii: S0264-410X(22)00760.
    >> Share

  31. SKIRROW H, Barnett S, Bell S, Mounier-Jack S, et al
    Women's views and experiences of accessing pertussis vaccination in pregnancy and infant vaccinations during the COVID-19 pandemic: A multi-methods study in the UK.
    Vaccine. 2022 Jul 1. pii: S0264-410X(22)00845.
    >> Share

  32. WYPLOSZ B, Fernandes J, Sultan A, Roche N, et al
    Pneumococcal and influenza vaccination coverage among at-risk adults: A 5-year French national observational study.
    Vaccine. 2022 Jul 7. pii: S0264-410X(22)00841.
    >> Share

  33. COURCIER EA, Collins SF, McCormick CM, Arnold ME, et al
    The impact of BCG strains and repeat vaccinations on immunodiagnostic tests in Eurasian badgers (Meles meles).
    Vaccine. 2022 Jul 9. pii: S0264-410X(22)00850.
    >> Share

  34. BASS JR, Poland GA
    Shoulder injury related to vaccine administration (SIRVA) after COVID-19 vaccination.
    Vaccine. 2022 Jun 8. pii: S0264-410X(22)00750.
    >> Share


    Virus Res

  35. ABDOLI M, Shafaati M, Ghamsari LK, Abdoli A, et al
    Intranasal administration of cold-adapted live-attenuated SARS-CoV-2 candidate vaccine confers protection against SARS-CoV-2.
    Virus Res. 2022 Jul 9:198857. doi: 10.1016/j.virusres.2022.198857.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016